Warfarin-Induced Skin Necrosis and Venous Limb Gangrene in the Setting of Heparin-Induced Thrombocytopenia

Archives of Internal Medicine

Volumn 164, Issue 1, 2004, Pages 66-70

  Srinivasan, Abhay F ^a   Rice, Lawrence ^a   Bartholomew, John R ^b   Rangaswamy, Chandhiran ^c   La Perna, Lucy ^b   Thompson, James E ^d   Murphy, Scott ^e   Baker, Kelty R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; PROTEIN C; THROMBIN INHIBITOR; WARFARIN;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL ARTICLE; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG ERUPTION; FEMALE; GANGRENE; HUMAN; HYPERCOAGULABILITY; IATROGENIC DISEASE; LEG; LEG AMPUTATION; MALE; MASTECTOMY; NECROSIS; PATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN NECROSIS; TERMINAL DISEASE; THROMBOCYTE; THROMBOCYTOPENIA;

ADULT; AGED; ANTICOAGULANTS; DRUG ERUPTIONS; FEMALE; GANGRENE; HEPARIN; HUMANS; LEG; MALE; MIDDLE AGED; NECROSIS; THROMBOCYTOPENIA; WARFARIN;

EID: 0347949656     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.1.66     Document Type: Article

References (18)

1. Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann HG. Protein C and the development of skin necrosis during anticoagulant therapy [letter]. Thromb Haemost. 1983;49:251.
2. Eby CS. Warfarin-induced skin necrosis. Hematol Oncol Clin North Am. 1993;7: 1291-1300.
3. Warkentin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol. 1998;35(suppl 5):9-16.
4. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101:502-507.
5. Warkentin TE, Elavathil LJ, Hayward CPM, et al. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med. 1997;127:804-812.
6. Shahak A, Posan E, Szucs G, et al. Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. Angiology 1996;47:725-727.
7. Warkentin TE, Sikov WM, Lillicrap DP. Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia. Am J Hematol. 1999; 62:44-48.
8. Drakos P, Uziely B, Nagler A, et al. Successful administration of low molecular weight heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis. Haemostasis. 1993;23:259-262.
9. Celoria GM, Steingart RH, Banson B, et al. Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia: a case report. Angiology. 1988;39:915-920.
10. Potzach B, Unkrig C, Madlener K, Greinacher A, Muller-Berghaus G. APC resistance and early onset of oral anticoagulation are high thrombotic risk factors in patients with heparin-associated thrombocytopenia (HAT) [abstract]. Ann Hematol. 1996;72(suppl 1):A6.
11. Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med. 2002;136:210-215.
12. Smythe MA, Warkentin TE, Stephens JL, et al. Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia. Am J Hematol. 2002;71:50-52.
13. Nguyen PH, Baker KR, Rice L. The magnitude of protime INR effect by the direct thrombin inhibitor lepirudin in patients with heparin-induced thrombocytopenia. Blood. 2002;100(suppl): 130b/Abstract 4001.
14. Rice L, Nguyen P, Vann A. Preventing complications in heparin-induced thrombocytopenia: alternative anticoagulants are improving patient outcomes. Postqrad Med. 2002;112:85-89.
15. Wallis DE, Workman DL, Lewis BE, et al. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med. 1999;106:629-635.
16. Wallis DE, Quintos R, Wehrmacher W, Messmore H. Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia. Chest. 1999;116: 1333-1338.
17. Warkentin TE. Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis. Ann Intern Med. 2001;135:589-593.
18. Crowther MA, Ginsberg JB, Kearon C, et al. A randomized trial comparing 5-mg and 10-mg warfarin therapy. Arch Intern Med. 1999;159:46-48